We are live on
!
Find out more
SRC
Shufro Rose & Co Portfolio holdings
AUM
$1.47B
1-Year Est. Return
19.38%
This Fund
S&P 500
This Quarter
Est. Return
+7.08%
1 Year Est. Return
+19.38%
3 Year Est. Return
+47.49%
5 Year Est. Return
+55.37%
10 Year Est. Return
+200.77%
AUM
$1.21B
AUM Growth
+$158M
(+15%)
Cap. Flow
+$11.5M
Cap. Flow
% of AUM
0.95%
Top 10 Holdings %
Top 10 Hldgs %
38.56%
Holding
345
New
37
Increased
103
Reduced
110
Closed
29
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
|
+$121M |
| 2 |
Distillate US Fundamental Stability & Value ETF
DSTL
|
+$16.1M |
| 3 |
Moderna
MRNA
|
+$14.8M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$11.4M |
| 5 |
IBM
IBM
|
+$9.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
|
+$41.5M |
| 2 |
Horizon Kinetics Inflation Beneficiaries ETF
INFL
|
+$34.8M |
| 3 |
Invesco BulletShares 2026 Corporate Bond ETF
BSCQ
|
+$32.2M |
| 4 |
Cisco
CSCO
|
+$18.5M |
| 5 |
JPMorgan Chase
JPM
|
+$11.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.58% |
| 2 | Healthcare | 9.87% |
| 3 | Consumer Discretionary | 9.58% |
| 4 | Financials | 8.26% |
| 5 | Industrials | 4.17% |
Similar funds
SVWAG
KRSITF
CWM
AAIM
SWA
VCP
PWMAG
ACM
Shufro Rose & Co's Q1 2024 Portfolio in Review
As of Q1 2024, Shufro Rose & Co held 345 positions worth $1.21B, up 15% from $1.05B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Shufro Rose & Co's Q1 2024 filing shows 37 new, 103 increased, 110 reduced and 29 closed positions. Its largest new stake was Moderna: 146,584 shares worth $15.6M. The largest sale was iShares iBonds Dec 2026 Term Corporate ETF, an estimated $41.5M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Shufro Rose & Co's largest Q1 2024 buy was Moderna: 146,584 shares worth $15.6M.
- Shufro Rose & Co added most to iShares iBonds Dec 2027 Term Corporate ETF in Q1 2024, an estimated $121M increase.
- Shufro Rose & Co's biggest Q1 2024 reduction was iShares iBonds Dec 2026 Term Corporate ETF, cutting an estimated $41.5M.
- Shufro Rose & Co fully exited Horizon Kinetics Inflation Beneficiaries ETF in Q1 2024, selling an estimated $34.8M.
- Shufro Rose & Co's ten largest holdings make up 39% of its $1.21B portfolio in Q1 2024.
- Shufro Rose & Co opened 37 new positions and closed 29 in Q1 2024.
- Shufro Rose & Co's portfolio value rose 15% quarter-over-quarter to $1.21B.
Based on Shufro Rose & Co's 13F filing for Q1 2024, filed 8 May 2024.